Pfizer Inc. emerged from the pandemic as the world’s most visible drugmaker, with the windfall from its coronavirus vaccine almost doubling its revenue in just one year. And now the shot, coupled with Pfizer’s Covid-19 antiviral pill, is poised to make up more than half of its expected $100 billion in sales in 2022. That’s left the company with a cash hoard of $28 billion and a big problem: how to engineer a second act.
The pressure is clearly on for Pfizer to show that the muscle it built during the pandemic won’t atrophy. Big Pharma companies don’t normally double revenue so quickly, and nobody expects that kind of growth to continue. But one thing’s clear: Pfizer can’t go back to the sluggish path it was on for years, when it largely grew by buying up other outfits with better drug candidates than it was able to discover in-house. Its stock has already fallen 25% in 2022 on fears that it might return to those ways, trailing the broader market and other drugmakers.
“Pfizer was boring before Covid,” says BMO Capital Markets Corp. analyst Evan David Seigerman. “They’re being penalized because either investors don’t see a future for Covid or they don’t have visibility into that future.”
Denne historien er fra October 10, 2022-utgaven av Bloomberg Businessweek US.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra October 10, 2022-utgaven av Bloomberg Businessweek US.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
Instagram's Founders Say It's Time for a New Social App
The rise of AI and the fall of Twitter could create opportunities for upstarts
Running in Circles
A subscription running shoe program aims to fight footwear waste
What I Learned Working at a Hawaiien Mega-Resort
Nine wild secrets from the staff at Turtle Bay, who have to manage everyone from haughty honeymooners to go-go-dancing golfers.
How Noma Will Blossom In Kyoto
The best restaurant in the world just began its second pop-up in Japan. Here's what's cooking
The Last-Mover Problem
A startup called Sennder is trying to bring an extremely tech-resistant industry into the age of apps
Tick Tock, TikTok
The US thinks the Chinese-owned social media app is a major national security risk. TikTok is running out of ways to avoid a ban
Cleaner Clothing Dye, Made From Bacteria
A UK company produces colors with less water than conventional methods and no toxic chemicals
Pumping Heat in Hamburg
The German port city plans to store hot water underground and bring it up to heat homes in the winter
Sustainability: Calamari's Climate Edge
Squid's ability to flourish in warmer waters makes it fitting for a diet for the changing environment
New Money, New Problems
In Naples, an influx of wealthy is displacing out-of-towners lower-income workers